Ardelyx (ARDX) EBITDA (2013 - 2026)
Ardelyx (ARDX) reported EBITDA of -$37.9 million for Q1 2026, up 7.91% on a YoY basis from -$35.1 million in Q1 2025, and down 11289.49% quarter-over-quarter from -$333000.0 in Q4 2025.
Ardelyx (ARDX) EBITDA (2013 - 2026) Analysis & Trends
Ardelyx has reported EBITDA for 14 years, with the latest figure at -$37.9 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 7.91% year-over-year to -$37.9 million; the trailing twelve-month figure through Mar 2026 stood at -$58.2 million (down 8.34% YoY), and the FY2025 full-year result was -$61.5 million, down 56.37% from the prior year.
- EBITDA for Q1 2026 stood at -$37.9 million, down from -$333000.0 in the prior quarter.
- The five-year high for EBITDA was $10.8 million in Q4 2022, with the low at -$41.2 million in Q1 2025.
- Historically, EBITDA has averaged -$16.0 million across 5 years, with a median of -$19.1 million in 2025.
- Annual changes were most pronounced in 2022 — EBITDA jumped 129.67% — and 2023, when it slumped 363.85%.
- Ardelyx's EBITDA stood at $10.8 million in 2022, then slumped by 363.85% to -$28.4 million in 2023, then jumped by 115.92% to $4.5 million in 2024, then tumbled by 107.37% to -$333000.0 in 2025, then sank by 11289.49% to -$37.9 million in 2026.
- The last three EBITDA figures came in at -$37.9 million (Q1 2026), -$333000.0 (Q4 2025), and -$807000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | -37.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.93 Mn |
| Dec 31, 2025 | -333,000.00 |
| Sep 30, 2025 | -807,000.00 |
| Jun 30, 2025 | -19.14 Mn |
| Mar 31, 2025 | -41.18 Mn |
| Dec 31, 2024 | 4.52 Mn |
| Sep 30, 2024 | -523,000.00 |
| Jun 30, 2024 | -16.54 Mn |
| Mar 31, 2024 | -26.76 Mn |
| Dec 31, 2023 | -28.38 Mn |
| Sep 30, 2023 | 6.64 Mn |
| Jun 30, 2023 | -17.31 Mn |
| Mar 31, 2023 | -26.74 Mn |
| Dec 31, 2022 | 10.76 Mn |
| Sep 30, 2022 | -22.90 Mn |
| Jun 30, 2022 | -26.96 Mn |
| Mar 31, 2022 | -28.15 Mn |
| Dec 31, 2021 | -36.24 Mn |
| Sep 30, 2021 | -43.59 Mn |
| Jun 30, 2021 | -45.18 Mn |